Purdue Pharma on Wednesday filed a new Chapter 11 reorganization plan with the U.S. Bankruptcy Court for the Southern District of New York to settle opioid-related claims involving the company for ...

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut-based ...

NATIONWIDE — New York Attorney General Letitia James on Tuesday, Nov. 18, secured the approval of Purdue Pharma’s bankruptcy plan after U.S. Bankruptcy Judge Sean Lane confirmed the plan in a bench ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...

A federal bankruptcy court on November 18 formally approved Purdue’s $7.4 billion Chapter 11 plan to settle thousands of opioid-related lawsuits. The plan requires (1) a $6.5 billion contribution from ...

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A federal judge on Wednesday allowed Purdue ...

The state of Connecticut will get $64 million from Purdue Pharma and the Sackler family for their role in the opioid crisis. It's part of a $7.4 billion settlement announced by the U.S. Bankruptcy ...

The $7.5 billion opioid settlement involving Purdue Pharma took a major step forward Nov. 14 after the U.S. Bankruptcy Court for the Southern District of New York said it will confirm the company’s ...

OxyContin maker Purdue Pharma paid its CEO $9 million and its board chairman nearly $4 million in the 12 months before the company’s bankruptcy filing last month, according to recently filed financial ...